| FENNEC PHARMACEUT. |
| Kanada |
| Gesundheit |
| CA31447P1009 / A12A5F |
| RV41 (Frankfurt) / FENC (NASDAQ) |
| FRA:RV41, ETR:RV41, RV41:GR, NASDAQ:FENC |
| - |
| https://fennecpharma.com/ |
|
Fennec Pharmaceuticals Inc. is a clinical-stage bi..
>Volltext.. |
| 225.67 Mio. EUR |
| 222.4 Mio. EUR |
| 33.13 Mio. EUR |
| -3.98 Mio. EUR |
| -5.61 Mio. EUR |
| -0.2 EUR |
| 15.41 Mio. EUR |
| 18.68 Mio. EUR |
| -6.61 Mio. EUR |
| 2.24 |
| -21.39% |
| -406.14% |
| - |
| - |
| - |
| FENNEC |
| 31.12.25 |